Search Within

Nagavarakishore Pillarsetty

Formats
  1. Journal Article (91)
  2. Meeting Abstract (36)
  3. Review (4)
  4. Book Section (1)
  5. Correspondence (1)
Groups
  1. Radiochemistry and Imaging Sciences Service (133)
  2. Radiology, Department of (133)
  3. GSK Faculty (105)
  4. Sloan Kettering Institute Postdocs (101)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (66)
  6. Sloan Kettering Institute Faculty (65)

More Groups

People
  1. Jason Lewis (54)
  2. Steven Larson (35)
  3. Teja Muralidhar Kalidindi (31)
  4. Gabriela Chiosis (19)
  5. Tony Taldone (16)
  6. Blesida Punzalan (14)

More People

Years
  1. 2025 (2)
  2. 2024 (8)
  3. 2023 (15)
  4. 2022 (10)
  5. 2021 (16)
  6. 2020 (17)

More Years

Publications
  1. Journal of Nuclear Medicine (28)
  2. Nuclear Medicine and Biology (12)
  3. Journal of Labelled Compounds and Radiopharmaceuticals (8)
  4. Clinical Cancer Research (6)
  5. Molecular Imaging and Biology (6)
  6. Cancer Research (5)

More Publications

Publishers
  1. Society of Nuclear Medicine (28)
  2. Springer (16)
  3. American Association for Cancer Research (13)
  4. Elsevier Science Inc. (13)
  5. American Chemical Society (9)
  6. Wiley Blackwell (9)

More Publishers

Results (133)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Synthesis of (124)I-labeled epichaperome probes and assessment in visualizing pathologic protein-protein interaction networks in tumor bearing mice
    Journal Article

    Sharma, S.; Kalidindi, T.; Joshi, S.; Digwal, C. S.; Panchal, P.; Burnazi, E.; Lee, S. G.; Pillarsetty, N.; Chiosis, G.
    STAR Protocols (2022)

    Fulltext@MSK | Save
  • Noninvasive imaging of CD4(+) T cells in humanized mice
    Journal Article

    Nagle, V. L.; Hertz, C. A. J.; Henry, K. E.; Graham, M. S.; Campos, C.; Pillarsetty, N.; Schietinger, A.; Mellinghoff, I. K.; Lewis, J. S.
    Molecular Cancer Therapeutics (2022)

    Fulltext@MSK | Save
  • Radioimmunotherapy targeting Delta-like ligand 3 in small cell lung cancer exhibits antitumor efficacy with low toxicity
    Journal Article

    Tully, K. M.; Tendler, S.; Carter, L. M.; Sharma, S. K.; Samuels, Z. V.; Mandleywala, K.; Korsen, J. A.; Reyes, A. M. D.; Piersigilli, A.; Travis, W. D.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Analysis of capecitabine metabolites in conjunction with digital autoradiography in a murine model of pancreatic cancer suggests extensive drug penetration through the tumor
    Journal Article

    Russell, J.; Fanchon, L.; Alwaseem, H.; Molina, H.; O'Donoghue, I.; Bahr, A.; de Stanchina, E.; Pillarsetty, N.; Humm, J. L.
    Pharmacology Research & Perspectives (2022)

    Fulltext@MSK | Save
  • Inhibitory monoclonal antibody targeting ADAM17 expressed on cancer cells
    Journal Article

    Saha, N.; Xu, K.; Zhu, Z.; Robev, D.; Kalidindi, T.; Xu, Y.; Himanen, J.; de Stanchina, E.; Pillarsetty, N. V. K.; Dimitrov, D. S.; more...
    Translational Oncology (2022)

    Fulltext@MSK | Save
  • Pharmacologically controlling protein-protein interactions through epichaperomes for therapeutic vulnerability in cancer
    Journal Article

    Joshi, S.; Gomes, E. D.; Wang, T.; Corben, A.; Taldone, T.; Gandu, S.; Xu, C.; Sharma, S.; Buddaseth, S.; Yan, P.; more...
    Communications Biology (2021)

    Fulltext@MSK | Save
  • Imaging of cancer γ-secretase activity using an inhibitor-based PET probe
    Journal Article

    Nie, P.; Kalidindi, T.; Nagle, V. L.; Wu, X.; Li, T.; Liao, G. P.; Frost, G.; Henry, K. E.; Punzalan, B.; Carter, L. M.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • ERK inhibition improves anti-PD-L1 immune checkpoint blockade in preclinical pancreatic ductal adenocarcinoma
    Journal Article

    Henry, K. E.; Mack, K. N.; Nagle, V. L.; Cornejo, M.; Michel, A. O.; Fox, I. L.; Davydova, M.; Dilling, T. R.; Pillarsetty, N.; Lewis, J. S.
    Molecular Cancer Therapeutics (2021)

    Fulltext@MSK | Save
  • Unambiguous stereochemical assignment of cyclo(Phe-Pro), cyclo(Leu-Pro), and cyclo(Val-Pro) by electronic circular dichroic spectroscopy
    Journal Article

    Domzalski, A.; Margent, L.; Vigo, V.; Dewan, F.; Pilarsetty, N. V. K.; Xu, Y.; Kawamura, A.
    Molecules (2021)

    Fulltext@MSK | Save
  • PARP-targeted auger therapy in p53 mutant colon cancer xenograft mouse models
    Journal Article

    Wilson, T.; Pirovano, G.; Xiao, G.; Samuels, Z.; Roberts, S.; Viray, T.; Guru, N.; Zanzonico, P.; Gollub, M.; Pillarsetty, N. V. K.; more...
    Molecular Pharmaceutics (2021)

    Fulltext@MSK | Save